Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Pflat In 2005: Revenue Will Be "Substantially Unchanged"

Apr 05 2005

• By Lee Kalowski

Related Content

Celebrex, Bextra Stabilizing After FDA Advisory Committee Review, Pfizer Says

Apr 05 2005

No Merger Needed: Pfizer Efficiency Program To Generate $4 Bil. In Savings

Apr 05 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window